WHITEHAWK THERAPEUTICS INC (WHWK)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.60-0.65%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · WHWK
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 7.1 | 26.0 | 24.4 | 15.2 | 14.0 | 14.0 | 20.2 | 20.2 | — | — | — | — | — | — | — |
| Cost of Revenues | — | 0.8 | 3.0 | 2.8 | 1.3 | 0.0 | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 22.6 | 29.8 | 36.7 | 44.5 | 40.2 | 18.5 | — | — | — | — | — | — | — | — | — | — |
| R&D Expenses | 63.5 | 91.0 | 51.0 | 48.9 | 32.7 | 19.7 | 15.0 | 12.8 | 17.9 | 12.1 | — | — | — | — | — | — |
| Operating Income | (86.1) | (114.4) | (67.5) | (71.9) | (62.7) | (111.2) | (2.5) | (24.4) | (11.2) | (21.4) | (16.6) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | 0.2 | 0.2 | 0.7 | 0.8 | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest & Investment Income | 6.3 | 6.2 | 3.9 | 6.4 | 2.4 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | (6.2) | (2.2) | 0.7 | 0.8 | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | 2.0 | 1.2 | 0.8 | (0.0) | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (20.6) | (63.7) | (65.8) | (60.5) | (110.1) | (3.5) | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (79.8) | (20.6) | (63.7) | (65.8) | (60.5) | (110.1) | (3.5) | (23.3) | (10.4) | (21.4) | (17.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.96) | (0.33) | (2.36) | (2.44) | (2.69) | (12.41) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.96) | (0.33) | (2.36) | (2.44) | (2.69) | (12.41) | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 82.9 | 61.9 | 27.0 | 26.9 | 22.5 | 8.9 | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 82.9 | 61.9 | 27.0 | 26.9 | 22.5 | 8.9 | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (114.3) | (67.3) | (71.8) | (62.5) | (111.1) | (2.5) | — | — | — | — | — | — | — | — | — |
| EBIT | (86.1) | (114.4) | (67.5) | (71.9) | (62.7) | (111.2) | (2.5) | (24.4) | (11.2) | (21.4) | (16.6) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | -0.0% | -0.1% | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.